TQB3909 Tablets in Subjects With Relapsed or Refractory Mantle Cell Lymphoma (MCL)

NCT06106841 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class

Stopped Study terminated for strategic business reasons

Conditions

Interventions

Sponsor

Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.